JP2014505061A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505061A5
JP2014505061A5 JP2013550864A JP2013550864A JP2014505061A5 JP 2014505061 A5 JP2014505061 A5 JP 2014505061A5 JP 2013550864 A JP2013550864 A JP 2013550864A JP 2013550864 A JP2013550864 A JP 2013550864A JP 2014505061 A5 JP2014505061 A5 JP 2014505061A5
Authority
JP
Japan
Prior art keywords
peptide according
peptide
inflammation
treatment
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013550864A
Other languages
Japanese (ja)
Other versions
JP2014505061A (en
JP6158712B2 (en
Filing date
Publication date
Priority claimed from EP11152213A external-priority patent/EP2481751A1/en
Application filed filed Critical
Publication of JP2014505061A publication Critical patent/JP2014505061A/en
Publication of JP2014505061A5 publication Critical patent/JP2014505061A5/ja
Application granted granted Critical
Publication of JP6158712B2 publication Critical patent/JP6158712B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (12)

以下のペプチド：
Figure 2014505061
 のうちのいずれか１つから選択されるペプチド。 The following peptides :
Figure 2014505061
 From any one selected Lupe Petit de of. 前記ペプチドが、以下：
Figure 2014505061
 である、請求項１に記載のペプチド。 The peptide is :
Figure 2014505061
 In it, peptide of claim 1. カルボキシ末端で遊離ＣＯＯＨが、ＣＯＮＨ2に変換される、請求項１又は２に記載のペプチド。 Free COOH at the carboxy terminus is converted to CONH 2, peptide according to claim 1 or 2. アミノ末端で遊離ＮＨ2基が、アミドＣＨ3ＣＯＮＨに変換される、請求項１〜３のいずれか１項に記載のペプチド。 Free NH 2 group at the amino terminus is converted to an amide CH 3 CONH, peptide according to any one of claims 1-3. アミノ酸Ｃｙｓが、存在する場合、アセトアミドメチル‐システインで置換される、請求項１〜４のいずれか１項に記載のペプチド。 The peptide according to any one of claims 1 to 4 , wherein the amino acid Cys, if present, is substituted with acetamidomethyl-cysteine. 医薬として使用するための、請求項１〜５のいずれか１項に記載のペプチド。 For use as a medical drug, a peptide according to any one of claims 1-5. 感染症、炎症、腫瘍、疼痛、創傷、及び瘢痕の治療及び／又は予防で使用するための、請求項１〜５のいずれか１項に記載のペプチド。 Infection, inflammation, tumor, pain, wounds, and for use in the treatment and / or prevention of scarring, the peptides according to any one of claims 1-5. 皮膚及び皮膚組織感染症並びに炎症の治療で使用するための、請求項７に記載のペプチド。 8. A peptide according to claim 7 for use in the treatment of skin and skin tissue infections and inflammation . 膿痂疹、火傷、感染した擦過傷、感染した裂傷、擦傷、丹毒、蜂巣炎、膿瘍、フルンケル、癰、閉鎖創、手術部位感染、二次的に感染した皮膚炎：アトピー性皮膚炎、乾癬、及びアレルギー性接触皮膚炎、動物咬傷、並びにカテーテル関連感染の治療、予防法（ｐｒｏｐｈｙｌａｘｉｓ）及び／又は予防で使用するための、請求項８に記載のペプチド。 Impetigo, burns, infected abrasions, infected lacerations, abrasions, erysipelas, cellulitis, abscess, Frunkel, hemorrhoids, closure wound, surgical site infection, secondary infected dermatitis: atopic dermatitis, psoriasis, 9. A peptide according to claim 8 for use in the treatment, prophylaxis and / or prevention of and allergic contact dermatitis, animal bites and catheter-related infections. 感染症、炎症、腫瘍、疼痛、創傷、及び瘢痕の治療及び／又は予防のための医薬を製造するための、請求項１〜５のいずれか１項に記載のペプチドの使用。 Use of a peptide according to any one of claims 1 to 5 for the manufacture of a medicament for the treatment and / or prevention of infectious diseases, inflammation, tumors, pain, wounds and scars . 請求項１〜５のいずれか１項に記載のペプチドを含む、医薬組成物。 A pharmaceutical composition comprising the peptide according to any one of claims 1 to 5 . 感染症、炎症、腫瘍、疼痛、創傷及び瘢痕の治療で使用するための、請求項１１に記載の医薬組成物。 Infection, inflammation, tumor, pain, for use in therapy of wounds and scars, pharmaceutical composition according to claim 1 1.
JP2013550864A 2011-01-26 2012-01-25 Novel synthetic peptides and their use Expired - Fee Related JP6158712B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11152213.2 2011-01-26
EP11152213A EP2481751A1 (en) 2011-01-26 2011-01-26 Human lactoferrin derived peptides
PCT/EP2012/051111 WO2012101156A2 (en) 2011-01-26 2012-01-25 New synthetic peptides and their use

Publications (3)

Publication Number Publication Date
JP2014505061A JP2014505061A (en) 2014-02-27
JP2014505061A5 true JP2014505061A5 (en) 2015-03-12
JP6158712B2 JP6158712B2 (en) 2017-07-05

Family

ID=44123487

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013550864A Expired - Fee Related JP6158712B2 (en) 2011-01-26 2012-01-25 Novel synthetic peptides and their use
JP2013550865A Expired - Fee Related JP6158713B2 (en) 2011-01-26 2012-01-25 Human lactoferrin-derived peptide and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013550865A Expired - Fee Related JP6158713B2 (en) 2011-01-26 2012-01-25 Human lactoferrin-derived peptide and use thereof

Country Status (13)

Country Link
US (2) US9132165B2 (en)
EP (3) EP2481751A1 (en)
JP (2) JP6158712B2 (en)
KR (2) KR101933900B1 (en)
CN (2) CN103459419B (en)
AU (2) AU2012210565B2 (en)
BR (2) BR112013018365A2 (en)
CA (2) CA2825247A1 (en)
ES (2) ES2633353T3 (en)
MX (2) MX341020B (en)
PL (1) PL2668205T3 (en)
RU (2) RU2593757C2 (en)
WO (2) WO2012101156A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
CN104888202A (en) * 2014-05-22 2015-09-09 闫牧乔 Drug for treating tonsillitis
IT201800002457A1 (en) * 2018-02-07 2019-08-07 Neilos S R L Composition for the prevention and treatment of respiratory tract diseases
RU2681216C1 (en) * 2018-09-05 2019-03-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации METHOD FOR STIMULATING REGENERATION OF INFECTED WOUNDS ON SKIN AND SOFT TISSUES USING Gly-His-Lys-D-Ala PEPTIDE
RU2681310C1 (en) * 2018-09-05 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации SKIN AND SOFT TISSUES INFECTED WOUNDS PRIMARY SURGICAL TREATMENT METHOD USING THE Gly-His-Lys-D-Ala PEPTIDE
KR102032945B1 (en) * 2018-12-03 2019-10-16 순천대학교 산학협력단 Peptides having anti-inflammatory activity and composition the same for anti-inflammatory
NL2024839B1 (en) * 2020-02-05 2021-09-13 Cbmr Scient Nanoscience B V Antimicrobial peptide for treatment and controlling skin disorders relating to microbial infection

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (en) 1990-09-07 1998-10-30 森永乳業株式会社 Antimicrobial peptides and antimicrobial agents
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3347819B2 (en) 1993-06-28 2002-11-20 森永乳業株式会社 Purification method of antimicrobial peptide
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
JP3529423B2 (en) 1994-04-01 2004-05-24 森永乳業株式会社 Method for producing antimicrobial peptide
JP3812957B2 (en) 1994-08-02 2006-08-23 森永乳業株式会社 Corneal injury treatment agent
JPH08143468A (en) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd Antiulcer agent
CA2263416A1 (en) 1996-08-12 1998-02-19 A + Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
SE9804614A0 (en) 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
AU5010800A (en) * 1999-05-14 2000-12-05 Regents Of The University Of California, The Anti-inflammatory therapy for inflammatory mediated infection
ATE313562T1 (en) 1999-11-11 2006-01-15 Am Pharma Bv ANTIMICROBIAL EFFECT OF THE FIRST CATIONIC CLUSTER OF HUMAN LACTOFERRIN
RU2165769C1 (en) * 2000-07-13 2001-04-27 Якубовская Раиса Ивановна Antibacterial, antioxidant, immunomodulating and anticancer preparation and method of its embodiment
SE0102067D0 (en) 2001-06-11 2001-06-11 A & Science Invest Ab Prevention of neovascularization of intervertebral discs and / or of tissues with local inflammation
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
ES2532392T3 (en) * 2006-07-10 2015-03-26 Pba3 Biomed Gmbh Antimicrobial peptides
JP5384948B2 (en) * 2007-02-09 2014-01-08 ジェノミディア株式会社 Novel polypeptide and antibacterial agent containing it as an active ingredient
JP5444544B2 (en) * 2007-02-09 2014-03-19 ジェノミディア株式会社 Angiogenesis inducer and polypeptide used therefor
EP2050461A1 (en) 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
EP2060586A1 (en) 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB New synthetic arginine substituted peptides and their use
ES2566830T3 (en) * 2008-05-23 2016-04-15 Daiichi Sankyo Company, Limited Peptide capable of extending the half-life of peptide of interest in plasma
PL2387390T3 (en) * 2009-01-13 2013-12-31 Pergamum Ab Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
KR101341210B1 (en) * 2013-01-24 2013-12-12 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 Novel antimicrobial peptide and use thereof

Similar Documents

Publication Publication Date Title
JP2014505061A5 (en)
JP2014505062A5 (en)
JP2015512386A5 (en)
JP2014521735A5 (en)
RU2008136324A (en) GASTROINTESTINAL PROLIFERATIVE FACTOR AND ITS APPLICATIONS
EA201101518A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY
NZ713202A (en) Diagnosis and treatments relating to th2 inhibition
EA201590166A8 (en) COMBINED THERAPY FOR THE TREATMENT OF SCATTERED SCLEROSIS
RU2013139294A (en) NEW SYNTHETIC PEPTIDES AND THEIR APPLICATION
RU2017127273A (en) SHORT ANTIMICROBIAL LIPOPEPTIDES
JP2011507845A5 (en)
BR112015025804A2 (en) glutarimide derivatives, their use, pharmaceutical composition based on them and methods for the production of glutarimide derivatives
RU2018106533A (en) NEW TRIPSIN ISOFORM AND THEIR APPLICATION
MX2023010328A (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof.
MX356343B (en) Compounds which inhibit neuronal exocytosis (ii).
JP2013541583A5 (en)
JP2013520448A5 (en)
MX2013000877A (en) Application of î²-functionalized dihydroxy-chlorins for pdt.
EA201270747A1 (en) COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF THE RAS
EA201500992A1 (en) LEDENET FOR TREATMENT OF THORN PAIN, CHOKING OF THE VOICE AND RELATED DRY Cough AND INFLAMMATORY DISEASES OF THE CAVITY AND THROAT
RU2014141515A (en) ANTIMICROBIC BANDBANDING MATERIAL, ANTIMICROBIAL DRUG AND THEIR APPLICATION
JP2015513554A5 (en)
JP2013147495A5 (en)
CL2018003268A1 (en) Carboxylic acids to treat / prevent a skin disease.
MX2019002657A (en) Combinations with a backbone-cyclized peptide.